key: cord-0064639-okobm9rq authors: Böthig, Ralf; Kowald, Birgitt; Fiebag, Kai; Balzer, Oliver; Tiburtius, Christian; Thietje, Roland; Kadhum, Thura; Golka, Klaus title: Bladder management, severity of injury and period of latency: a descriptive study on 135 patients with spinal cord injury and bladder cancer date: 2021-06-17 journal: Spinal Cord DOI: 10.1038/s41393-021-00651-3 sha: 75fda3a634753b73ef6d53a1347a7ac89466852c doc_id: 64639 cord_uid: okobm9rq STUDY DESIGN: Longitudinal study. OBJECTIVES: To describe the severity of spinal cord injury/disease (SCI/D), type and management of neurogenic lower urinary tract dysfunction, tumor characteristics, and bladder cancer latency period in SCI/D patients. SETTING: Spinal cord injury centers in Germany, Austria, and Switzerland. METHODS: Data of SCI/D patients diagnosed with bladder cancer were collected between Jan 2012–Dec 2019 in the course of annual surveys in the neuro-urological departments of all 28 centers. Demographic and paralysis-specific data, data on the type and management of neurogenic lower urinary tract dysfunction, and histopathological tumor characteristics were collected. RESULTS: Regarding histopathological tumor characteristics, no significant differences were found in 135 individuals with SCI/D when stratified for bladder management without chronic catheterization, SCI/D severity, and ASIA classification. The mean latency period between the onset of SCI/D and the diagnosis of bladder cancer was significantly longer in patients with catheter-free emptying methods compared to patients with intermittent catheterization, and in patients with LMNL (Lower Motor Neuron Lesion) compared to patients with UMNL (Upper Motor Neuron Lesion). CONCLUSIONS: Urinary bladder carcinomas are late events in the long-term course of SCI/D. Follow-up and approaches to screening must therefore be intensified with increasing duration of long-term SCI. Worldwide, bladder cancer is the 10th most common form of cancer, with an estimated 549,000 new cases and 200,000 deaths in 2018. The incidence and mortality rates are estimated at 9.6 and 3.2 for men and 2.4 and 0.9 per 100,000 for women. Men are thus affected about 4 times more often than women [1] . According to a current estimate, 25-30 million people worldwide live with spinal cord injury/disease (SCI/D); the annual incidence (2016) worldwide is almost one million new cases [2] . Due to medical progress, the life expectancy of persons with SCI/D has improved dramatically in recent decades [3] . Thus, cancer is currently the third most cause of death in individuals with SCI/D, and bladder cancer is the second most common tumor after lung cancer [4] . Against this background, the question of a possible causal relationship between SCI/D and the occurrence of bladder cancer has gained much interest in recent years. Due to incoherent data, the question of the incidence of bladder cancer in SCI/D patients has long been unclear. Two systematic reviews covering data from 1966 to 2007 [5] and from 1963 to 2014 [6] have recently calculated a "pooled incidence rate" which is at 0.33% and 0.60%, respectively. Several studies in recent years have consistently identified the following special features in patients with SCI/D and bladder cancer [7] : Bladder cancer in patients with SCI/D is usually diagnosed one to two decades earlier than in the general population, it is characterized by a more advanced stage of the primary tumor (higher T category) and it is a more aggressive disease. The same unfavorable tumor characteristics and the earlier onset of the disease were previously reported in SCI/D patients treated without permanent indwelling catheters [8] . The aforementioned tumor characteristics lead to a 6.7fold higher bladder cancer mortality rate in people with SCI/D compared to the general population [9] , which increases with the duration of paralysis [9] . Therefore, bladder cancer in SCI/D patients remains a challenge for clinicians particularly regarding timely diagnosis and for basic scientists in elucidating pathophysiological mechanisms. Especially in view of the often poor prognosis, an effective screening strategy that is as little burdensome as possible and cost-effective is urgently needed. Unfortunately, such a strategy has not yet been established in the concept of lifelong surveillance of SCI/D patients [10] . Elliott [11] has clearly pointed out that at the current state of knowledge screening of individuals with SCI/D for bladder cancer is not justified. It is of utmost importance to identify SCI/D subpopulations with a sufficiently high risk that would justify screening measures leading to better chances of survival and/or higher quality of life. This paper aims to contribute to a better definition of a starting point for bladder cancer screening in SCI/D patients, to evaluate the possible influence of bladder management and type of bladder dysfunction on bladder cancer risk, and to elucidate a possible relationship between injury grade or ASIA classification and bladder cancer risk. Data of paraplegic patients with newly diagnosed histologically confirmed bladder cancer were collected between January 1st, 2012 and December 31st, 2019 in the course of annual surveys. All 28 neuro-urological departments of the paraplegic centers in Germany, Austria, and Switzerland affiliated in the German-speaking Medical SCI Society (Deutschsprachige Medizinische Gesellschaft für Paraplegiologie, DMGP) participated in this study. Demographic and paralysis-specific data on pre-existing SCI/D, data on the type and management of neurogenic lower urinary tract dysfunction (NLUTD), and all tumor characteristics (tumor type, T category, and grading) were collected entirely by an electronic questionnaire. The study included all SCI/D patients presented to the participating departments as inpatient or outpatient within the study period, including 28 Hamburg patients previously published [8] . There was no specific screening strategy for urinary bladder tumors in the departments involved, so the tumors were diagnosed if they became symptomatic with hematuria, hydronephrosis, or frequently recurrent urinary tract infections or as incidental findings e.g., at diagnostics or treatment of complications or during regular "check-up" procedures (mostly sonographically or cystoscopically). The neurological level of SCI/D was classified according to the International Standards for Neurological Classification of SCI (ISNCSCI) and the severity (degree of impairment) was classified in accordance with the American Spinal Injury Association (ASIA) Impairment Scale (AIS) [12] . Neurologic level of injury and severity of the SCI/D were categorized as follows: C1-4 AIS A, B, and C; C5-8 AIS A, B, and C; T1-S3 AIS A, B, and C; AIS D at any injury level [13] . The type of bladder paralysis and assignment as UMNL (Upper Motor Neuron Lesion with detrusor overactivity) or LMNL (Lower Motor Neuron Lesion with areflexia or flaccid paralysis of the urinary bladder muscle) was confirmed by video-urodynamic examination in all patients included. All bladder tumors were classified according to the WHO 2016 Classification of Tumors of the Urinary System [14] . For details, see Supplementary TNM Information. The data were entered into a database and pseudonymized during entry. The data are presented as mean and standard deviation (SD) or median and 25% and 75% quartile, depending on the presence or absence of a normal distribution. The latter was tested by the Shapiro-Wilk-Test. Frequencies or proportions are reported as percentages with a 95% confidence interval (CI). Binomial confidence intervals were calculated using the Clopper-Pearson interval method. The post-hoc mean comparison was performed with the Tuckey test; the 95% confidence intervals of the differences were calculated. Statistical analyses were conducted using SAS 9.4 software (SAS Institute Inc., Cary, NC, USA). All applicable institutional and governmental regulations concerning the ethical use of the data were observed. The ethics committee of the University of Lübeck (AZ 17-345A) and the Institutional Review Board (Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services, address: Pappelallee 33, 22089 Hamburg) both approved the study. This study includes 135 individuals with SCI/D from 22 of the participating 28 SCI centers in the German-speaking area (Suppl. Table 1 ). In 6 centers, no bladder cancer cases were observed during the study period. Baseline demographic data, SCI/D-related data, data on the type of bladder paralysis and bladder management, as well as tumor characterization data, are presented in Table 1 . Figure 1 shows the frequencies of the relevant tumor characteristics T category, grading, and tumor type stratified for the applied bladder management with and without intermittent catheterization. There were no evident differences between intermittent catheterization and the other bladder emptying methods (i.e., no catheter use) Table 2 presents the frequencies of T categories (